HEALTH CARE RESOURCE UTILIZATION AND ASSOCIATED COSTS AMONG LOWER-RISK MYELODYSPLASTIC SYNDROME PATIENTS IN FRANCE: EDELWEISS STUDY

被引：0
|
作者：
Comont, T. [1 ]
Fernandes, J. [2 ]
Chartier, M. [3 ]
Cotte, F. E. [4 ]
Pages, N. [5 ]
Panes, A. [5 ]
Schmidt, A. [5 ]
Webert, L. [3 ]
D. Aveni-Piney, M. [6 ]
机构：
[1] CHU Toulouse, Toulouse, France
[2] Ctr Hosp Cote Basque, Bayonne, France
[3] Bristol Myers Squibb, Rueil Malmaison, France
[4] Bristol Myers Squibb, Rueil Malmaison 92, France
[5] HEVA, Lyon, France
[6] CHRU Nancy, Nancy, France
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
SA67
引用
收藏
页码：S627 / S627
页数：1
相关论文
共 50 条
  • [1] Cause of Death in Patients With Lower-Risk Myelodysplastic Syndrome
    Dayyani, Farshid
    Conley, Anthony P.
    Strom, Sara S.
    Stevenson, William
    Cortes, Jorge E.
    Borthakur, Gautam
    Fader, Stefan
    O'Brien, Susan
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    CANCER, 2010, 116 (09) : 2174 - 2179
  • [2] The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome
    Falantes, Jose F.
    Marquez-Malaver, Francisco J.
    Knight, Teresa
    Calderon-Cabrera, Cristina
    Martino, Maria L.
    Gonzalez, Jose
    Montero, Isabel
    Espigado, Ildefonso
    Perez-Simon, Jose A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 1893 - 1902
  • [3] Relations Between Family Functioning and Health State of Patients With Lower-Risk Myelodysplastic Syndrome
    Lu, Ying
    Zou, Yong
    Zhang, Jingwen
    Lin, Zhesheng
    Chen, Yuchan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C242 - C242
  • [4] Cause of death in patients with lower-risk myelodysplastic syndrome (MDS)
    Conley, A. P.
    Stevenson, W.
    Pierce, S.
    Cortes, J. E.
    O'Brien, S. M.
    Ravandi, F.
    Kantarjian, H. M.
    Garcia-Manero, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Lee, Kyoo-Hyung
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : E4 - E7
  • [6] Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
    Kantarjian, Hagop
    Fenaux, Pierre
    Sekeres, Mikkael A.
    Becker, Pamela S.
    Boruchov, Adam
    Bowen, David
    Hellstrom-Lindberg, Eva
    Larson, Richard A.
    Lyons, Roger M.
    Muus, Petra
    Shammo, Jamile
    Siegel, Robert
    Hu, Kuolung
    Franklin, Janet
    Berger, Dietmar P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 437 - 444
  • [7] HEALTH CARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH COMORBIDITIES AMONG HIV-POSITIVE PATIENTS
    Lachaine, J.
    Baribeau, V
    Lorgeoux, R.
    Tossonian, H.
    VALUE IN HEALTH, 2017, 20 (05) : A360 - A361
  • [8] Dose-reduced decitabine for lower-risk myelodysplastic syndrome patients
    Fang, B.
    He, G.
    Miao, M.
    Wang, X.
    Qiu, H.
    Jin, Z.
    Tang, X.
    Han, Y.
    Fu, Z.
    Ma, X.
    Sun, A.
    Wu, D.
    Ruan, C.
    LEUKEMIA RESEARCH, 2013, 37 : S164 - S165
  • [9] Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
    Mozessohn, Lee
    Li, Qing
    Liu, Ning
    Leber, Brian
    Khalaf, Dina
    Sabloff, Mitchell
    Christou, Grace
    Yee, Karen
    Chodirker, Lisa
    Parmentier, Anne
    Siddiqui, Mohammed
    Mamedov, Alexandre
    Zhang, Liying
    Liu, Ying
    Earle, Craig C.
    Cheung, Matthew C.
    Mittmann, Nicole
    Buckstein, Rena
    JCO ONCOLOGY PRACTICE, 2023, 19 (04) : 210 - +
  • [10] Allogeneic Stem Cell Transplantation for Patients with Lower-Risk Myelodysplastic Syndrome
    Novak, Polona
    Zabelina, Tatjana
    Wolschke, Christine
    Ayuk, Francis
    Christopeit, Maximilian
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2047 - 2052
12345